Form 4 · Filed Jun 30, 2026, 09:25 PM UTC
HALO/HALOZYME THERAPEUTICS, INC.
Krishnan Mahesh — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 29, 2026 | M | other | 7,304 | $38 | $280,912 | 21,766 |
| Jun 29, 2026 | S | sell | 7,304 | $75 | $547,800 | 14,462 |
| Jun 29, 2026 | M | other | 7,304 | — | — | 1,500 |
Source: SEC EDGAR raw filing ↗ · Accession 0001159036-26-000082